Tuesday, April 15, 2014 4:55:40 PM
This has been a dead issue up until recently, and until something more is announced, it still is. Thankfully, the two guys getting the shares one have been around this one for a long time, so a sudden direction into the newest, scammiest 'medical' trend isn't likely.
That being said, it's still a pump. There is money to be made, but it's a dead company with no operations, with an almost 4 billion OS that was left behind in its field long ago.
Trade it, make money off of it, but don't fall for the hype.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM